249 related articles for article (PubMed ID: 31513003)
1. In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
Kalirajan R; Pandiselvi A; Gowramma B; Balachandran P
Curr Drug Res Rev; 2019; 11(2):118-128. PubMed ID: 31513003
[TBL] [Abstract][Full Text] [Related]
2. Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer - An in-silico approach.
Rajagopal K; Sri VB; Byran G; Gomathi S
Curr Drug Res Rev; 2022; 14(1):61-72. PubMed ID: 34139975
[TBL] [Abstract][Full Text] [Related]
3. In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer's Disease.
V P; A M; N R
Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38204222
[TBL] [Abstract][Full Text] [Related]
4. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
Rajagopal K; Varakumar P; Aparna B; Byran G; Jupudi S
J Biomol Struct Dyn; 2021 Sep; 39(15):5551-5562. PubMed ID: 32720578
[TBL] [Abstract][Full Text] [Related]
5. An
Malkaje S; Srinivasa MG; Deshpande N S; Navada S; Revanasiddappa Bc
Curr Drug Res Rev; 2023; 15(1):88-100. PubMed ID: 36017854
[TBL] [Abstract][Full Text] [Related]
6. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
[TBL] [Abstract][Full Text] [Related]
7. Novel Thiazine Substituted 9-Anilinoacridines: Synthesis, Antitumour Activity and Structure Activity Relationships.
Kalirajan R; Gaurav K; Pandiselvi A; Gowramma B; Sankar S
Anticancer Agents Med Chem; 2019; 19(11):1350-1358. PubMed ID: 30961512
[TBL] [Abstract][Full Text] [Related]
8.
Rajagopal K; Kalusalingam A; Bharathidasan AR; Sivaprakash A; Shanmugam K; Sundaramoorthy M; Byran G
Molecules; 2023 May; 28(10):. PubMed ID: 37241915
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and docking studies of peptidomimetics based on HER2-herceptin binding site with potential antiproliferative activity against breast cancer cell lines.
Satyanarayanajois S; Villalba S; Jianchao L; Lin GM
Chem Biol Drug Des; 2009 Sep; 74(3):246-57. PubMed ID: 19703026
[TBL] [Abstract][Full Text] [Related]
10. Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches.
Rampogu S; Son M; Baek A; Park C; Rana RM; Zeb A; Parameswaran S; Lee KW
Comput Biol Chem; 2018 Jun; 74():327-338. PubMed ID: 29702367
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent.
Mokale SN; Sakle NS; Bhavale SA; Lokwani DK; Shelke VR
Anticancer Agents Med Chem; 2018; 18(7):1009-1015. PubMed ID: 29189180
[TBL] [Abstract][Full Text] [Related]
13. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
14. Computational analyses of curcuminoid analogs against kinase domain of HER2.
Yim-im W; Sawatdichaikul O; Semsri S; Horata N; Mokmak W; Tongsima S; Suksamrarn A; Choowongkomon K
BMC Bioinformatics; 2014 Aug; 15(1):261. PubMed ID: 25089037
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An
Jubie S; Durai U; Latha S; Ayyamperumal S; Wadhwani A; Prabha T
Curr Drug Res Rev; 2021; 13(1):73-83. PubMed ID: 32955008
[TBL] [Abstract][Full Text] [Related]
16.
Alamri A; Rauf A; Khalil AA; Alghamdi A; Alafnan A; Alshammari A; Alshammari F; Malik JA; Anwar S
Biomed Res Int; 2021; 2021():9734279. PubMed ID: 34957309
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based Discovery of Potential Anticancer Lead: Computational and in vitro Studies.
Balgoname AA; Alomair SM; AlMubirek AK; Khedr MA
Curr Comput Aided Drug Des; 2021; 17(3):421-428. PubMed ID: 32586261
[TBL] [Abstract][Full Text] [Related]
18. Quantitative structure-activity relationships (QSAR) for 9-anilinoacridines: a comparative analysis.
Gao H; Denny WA; Garg R; Hansch C
Chem Biol Interact; 1998 Nov; 116(3):157-80. PubMed ID: 9920460
[TBL] [Abstract][Full Text] [Related]
19. Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach.
Lamichhane S; Rai RP; Khatri A; Adhikari R; Shrestha BG; Shrestha SK
J Biomol Struct Dyn; 2023 Feb; 41(3):897-911. PubMed ID: 34957911
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives.
Al-Jaidi BA; Telfah ST; Bardaweel SK; Deb PK; Borah P; Venugopala KN; Bataineh YA; Al Khames Aga QA
Curr Drug Metab; 2021; 22(7):532-536. PubMed ID: 33334285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
